Study: Children With Alopecia Areata Respond to Tofacitinib

The chart review summarized the results in 11 pediatric patients, ages 8 to 18 years, all with a diagnosis of alopecia areata, who were treated with tofacitinib.
Medscape Medical News

source https://www.medscape.com/viewarticle/968410?src=rss

Comments

Popular posts from this blog

DC’s Harllee Harper Is Using Public Health Tools to Prevent Gun Violence. Will It Work?